The DIAMA project is assessing and validating the Deeplex®-MycTB test in Africa and Europe. This rapid molecular test (based on mass sequencing) detects and genotypes mycobacteria and predicts antituberculosis drug resistance in Mycobacterium tuberculosis complex strains.

Partners:

  • Centre National Hospitalier de Pneumo-Phtisiologie - Benin
  • Prins Leopold Instituut voor Tropische Geneeskunde – Belgium
  • Université des Sciences, des Techniques et des Technologies de Bamako (USTTB) – Mali
  • London School of Hygiene and Tropical Medicine (LSHTM) – UK
  • Service de Pneumophtisiologie de l’Hôpital National Ignace Deen – Guinea
  • Jimma University – Ethiopia
  • Université Catholique de Louvain (UCL) – Belgium
  • The Bamenda Center for Health Promotion and Research – Cameroun
  • Institute National of Research Biomedical of Zaire (INRB) – Congo
  • Damien Foundation – Belgium
  • Rwanda Biomedical Center (RBC) – Rwanda
  • University Cheikh Anta Diop – Senegal
  • World Health Organization

Funding:

horizon2020

By continuing your visit to this site, you accept the use of statistics cookies